Member Info for RorkesDrift

Given

1. LFDs are in short supply (see media)
2. LFD will substitute for PCR in next 9 days (half term, see media)

What capacity have Avacta said they currently have in place. How much have they said they are working towards.

Actual numbers would help the calculation I am working on. Warm feelings and intentions are lovely but are c0ck all use. They can help with interpretation but at moment just facts.

Apologies. Fat fungers. How does someone prove they have a negative LFD?

Crack that and IG looks like PCR will be relegated. Did you see what I did there?

What are the requirements first oroof of LFD result?

Putting aside another post about his Lordship by his Lordship (ego or what) I think we cab agree that the company are working on HUA as are M19. We can all therefore predict that news will arrive. This will be good for Avacta.

The newspapers and television also carry news that there will be a move from PCR to LFD. This will also be good for Avacta.

Sharing information with other Board members is a great tubing to do - hey even opinion and interpretation is fine.

Pretending to have been RELIABLY informed on information that others wouldn't have access to in order to great a persona, sausage whacking anyone who questions it and being wrong on every occasion whilst trading on share movements probably doesn't qualify.

Making it about you detracts from the clear and obvious fact you have an agenda. If that agenda is about yiurvego please, please seek professional help.

https://www.theguardian.com/business/2021/oct/13/airline-and-travel-bosses-attack-uks-covid-travel-and-testing-rules?CMP=Share_AndroidApp_Other

You need to get an account for your dog. Tuppence is available and even has his / her own twitter account. Has been known to like posts in order to get the number up

Tuppence if you have been kidnapped and need a life free of perpurual trips to McDs rec this post

Makes a lot of sense that there is changes before half term - so we expect announcement within next 10 days.

Had to laugh earlier - talking about affimers being protein therefore impossible to be toxic. Not sure which medical text book he got that from.

The fact that AVA006 isn't affimer also seems to have passed him by.

If he was actually predicting something that turned out correct I can see that he provides support. The fact that he has yet to get one right despite multiple attempts suggest his motives are other than helping investors. Not sure if it is anything other than him just massaging his own ego and other parts.

I'm looking to forward to seeing how his latest trip to McDs turns out. Cannot lose.

Is it September already?

It will be Q2. Apply standard Avacta timeline adjustment.

Until then, sit back relax

Where is the Reverend Ken when you need him.

I'm going to send him the wiki pages for dose response curve and therapeutic window.

Nothing wrong with being positive but given the endless reference to his war stories I'm surprised that he dismisses the scientific method and GCP so readily.

I'm sure MHRA, EMEA and FDA will be thrilled to receive a phase 1 study with three patients at 90% of standard dose of being conclusive

For more stable readers the trial in its entirety has been set up to investigate a number of parameters. It has started at a conservative dose and will progress from there to ensure risk to patients are minimised. It was always going to be multi centre, they were always going to start at different times.

The trial is great. We will get the readout when it stops. There is no need to create fantasies about what no news means.

Makes me wonder why they are bothering with a trial.

Last update was its a multi centre trial with one patient recruited who had three doses at 90%. Trial progresses as planned

Turning no more news into a vivid and detailed story about trial progress and patient outcones is just odd.

No need. There will be news eventually, one way or the other

AS mentions billions of test, mid summer 2020, margin of £10+, no fund raiser needed (two weeks before doing opposite and announcing he had been negotiating for about year).

I understand it is difficult and he may even have persuaded himself - might partly explain the silent running.

Question is - is the lack of info on LFD progression in the interest of share holders. Information is key to good investment decisions so whose interest is it in not to say how many are being produced and how many sold - not after a daily update but last presentation was a perfect opportunity.

I'm thinking people should try standing outside

Timster am bythe

In terms of immunotherapy being expensive.

May I just check you understand the principles of the price :profit curve, pharmaceutical life cycle management and the role of pricing regulation.

Yep see Benx4 post below or above

Bump